Onderneming Hualan Biological Engineering Inc.
Aandelen
002007
CNE000001JN8
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
19,81 CNY | +2,27% | -0,55% | -10,48% |
Vakgebied
Aantal werknemers: 3 243
Verkoop per activiteit
CNY in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
Flu Vaccine
40,2
%
| 1 825 | 41,1 % | 1 818 | 40,2 % | -0,39% |
Human Serum Albumin
21,9
%
| 1 011 | 22,8 % | 988 | 21,9 % | -2,29% |
Other Blood Products
20,3
%
| 878 | 19,8 % | 916 | 20,3 % | +4,37% |
Intravenous Gamma Injection
17,2
%
| 709 | 16,0 % | 775 | 17,2 % | +9,33% |
Other
0,4
%
| 14 | 0,3 % | 20 | 0,4 % | +46,26% |
Verkoop per regio
CNY in miljoen | 2021 | Gewicht | 2022 | Gewicht | Delta |
---|---|---|---|---|---|
China
99,6
%
| 4 429 | 99,8 % | 4 499 | 99,6 % | +1,58% |
Foreign
0,4
%
| 7 | 0,2 % | 18 | 0,4 % | +157,52% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Bei Fan
CEO | Chief Executive Officer | 52 | 30-03-92 |
Jun Min Xie
DFI | Director of Finance/CFO | 56 | 01-10-10 |
Kang An
CHM | Chairman | 75 | 01-03-92 |
Xiao Wei Ma
CTO | Chief Tech/Sci/R&D Officer | 56 | 12-04-07 |
Wen Jue An
BRD | Director/Board Member | 35 | 01-06-15 |
Yan Chao Wang
BRD | Director/Board Member | 35 | 01-07-11 |
Wen Qi An
BRD | Director/Board Member | 45 | 01-07-09 |
Bao Xian Zhang
BRD | Director/Board Member | 53 | 26-03-08 |
Ruo Wen Pan
BRD | Director/Board Member | 56 | 01-02-93 |
Yuan Cheng Lou
IRC | Investor Relations Contact | 40 | 01-06-08 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kang An
CHM | Chairman | 75 | 01-03-92 |
Bei Fan
CEO | Chief Executive Officer | 52 | 30-03-92 |
Ruo Wen Pan
BRD | Director/Board Member | 56 | 01-02-93 |
Xiao Wei Ma
CTO | Chief Tech/Sci/R&D Officer | 56 | 12-04-07 |
Bao Xian Zhang
BRD | Director/Board Member | 53 | 26-03-08 |
Yun Long Wang
BRD | Director/Board Member | 62 | 15-04-20 |
Zhi Guo Su
BRD | Director/Board Member | 70 | - |
Lin Lin Cai
BRD | Director/Board Member | 38 | 01-04-08 |
Wen Qi An
BRD | Director/Board Member | 45 | 01-07-09 |
Wan Li Liu
BRD | Director/Board Member | 43 | 15-04-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 1 828 780 926 | 954 133 137 ( 52,17 %) | 0 | 52,17 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,48% | 5,01 mld. | |
+0,44% | 90,78 mld. | |
+9,61% | 43,96 mld. | |
-16,67% | 31,34 mld. | |
+44,99% | 23,45 mld. | |
-9,42% | 16,48 mld. | |
-25,92% | 15,03 mld. | |
-9,27% | 12,79 mld. | |
-7,57% | 12,19 mld. | |
+0,07% | 8,5 mld. |
- Beurs
- Aandelen
- Aandeel Hualan Biological Engineering Inc. - Shenzhen S.E.
- Onderneming Hualan Biological Engineering Inc.